Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Ventrix Inc.
DescriptionInjectable hydrogel scaffold sourced from decellularized porcine cardiac connective tissues
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationCongestive heart failure (CHF)
Indication DetailsPrevent congestive heart failure (CHF) following myocardial infarction (MI)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today